Literature DB >> 10447025

A commentary on the pathogenesis of pertussis.

E L Hewlett1.   

Abstract

In recent years a great deal of information has been generated on the virulence factors produced by Bordetella pertussis, the regulation of their expression, and their molecular mechanisms of action. There are numerous studies of Bordetella virulence factors and strains of B. pertussis in which the genes for some of these components have been mutated or deleted. In addition, several acellular vaccines composed of these virulence factors have been developed, tested, and licensed for use in the prevention of pertussis. Nevertheless, there exists little information specifically on the pathogenesis of the disease process caused by B. pertussis in humans, and such data are necessary for adequate understanding and treatment of this novel infectious disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10447025     DOI: 10.1086/515055

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  3 in total

1.  Pertussis toxin inhibits neutrophil recruitment to delay antibody-mediated clearance of Bordetella pertussis.

Authors:  Girish S Kirimanjeswara; Luis M Agosto; Mary J Kennett; Ottar N Bjornstad; Eric T Harvill
Journal:  J Clin Invest       Date:  2005-11-17       Impact factor: 14.808

2.  Shift in the epidemiology of pertussis infection: an indication for pertussis vaccine boosters for adults?

Authors:  Sylvia H Yeh; ChrisAnna M Mink
Journal:  Drugs       Date:  2006       Impact factor: 9.546

3.  International Bordetella pertussis assay standardization and harmonization meeting report. Centers for Disease Control and Prevention, Atlanta, Georgia, United States, 19-20 July 2007.

Authors:  M L Tondella; G M Carlone; N Messonnier; C P Quinn; B D Meade; D L Burns; J D Cherry; N Guiso; E L Hewlett; K M Edwards; D Xing; A Giammanco; C H Wirsing von König; L Han; L Hueston; J B Robbins; M Powell; C M Mink; J T Poolman; S W Hildreth; F Lynn; A Morris
Journal:  Vaccine       Date:  2008-12-09       Impact factor: 3.641

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.